JP MORGAN/CALL/BOSTON SCIENTIFIC/82/0.1/17.01.25 | Delayed Börse Stuttgart 04:57:21 2024-07-17 am EDT | ||
| 0.66 EUR | -1.49% |
|
| Current month | +1.54% | ||
| 3 months | +50.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BOSTON SCIENTIFIC CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 0.66 | -1.49% |
| 24-07-16 | 0.67 | -6.94% |
| 24-07-15 | 0.72 | +20.00% |
| 24-07-12 | 0.6 | -4.76% |
| 24-07-11 | 0.63 | +8.62% |
Delayed Quote Börse Stuttgart
Last update July 17, 2024 at 04:57 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | BOSTON SCIENTIFIC CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK6ZH3 |
| ISIN | DE000JK6ZH35 |
| Date issued | 2024-04-10 |
| Strike | 82 $ |
| Maturity | 2025-01-17 (184 Days) |
| Parity | 10 : 1 |
| Emission price | 0.21 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.76 € |
|---|---|
| Lowest since issue | 0.38 € |
| Spread | 0.05 € |
| Spread % | 7.25% |
Company Profile
Boston Scientific Corporation specializes in the design, manufacturing and marketing of medical equipment and materials. Net sales break down by area of application as follows:
- cardiovascular (60.6%): products used in cardiology surgeries (27.4% of net sales), cardiac rhythm management (25.2%), peripheral surgeries (23.9%), electrophysiology tests (9.1%) and other (14.4%);
- endodontic surgery (37.4%): equipment used in endoscopy (45.8% of net sales), urology (36.2%) and other (18%) ;
- neuromodulation (2%).
The United States account for 59.2% of net sales.
Sector
-
Ratings for Boston Scientific Corporation
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Boston Scientific Corporation
Sell
Buy
Mean consensus
BUY
Number of Analysts
32
Last Close Price
77.41
USD
Average target price
84.1
USD
Spread / Average Target
+8.64%
- Stock Market
- Warrants
- Warrant
